Pfizer prepares to rid itself of animal health, nutrition units
This article was originally published in Scrip
Pharma king Pfizer has taken the first step in following through with earlier revealed plans to strip itself of its animal health and nutrition businesses, disclosing on 7 July that it was considering a full or partial separation through a spin-off, sale or other transaction, but said it intends to hold on to its consumer health unit and its so-called established products business, which includes its generics and biosimilars.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.